Sonnet BioTherapeutics Holdings, Inc (SONN)

Etorro trading 970x250
Sonnet BioTherapeutics Holdings, Inc (SONN) Logo

About Sonnet BioTherapeutics Holdings, Inc

Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding (FHAB) technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate includes SON-080, a human version of low dose Interleukin-6 (IL-6), which has completed Phase I trials for the treatment of patients with chemotherapy-induced peripheral neuropathy. The company is also developing SON-081, a low dose IL-6 for the treatment of patients with diabetic peripheral neuropathy and is under phase I trials; SON-1010, a FHAB derived compound, which utilizes a human version of Interleukin-12 (IL-12) is under pre-clinical trial, as well as SON-1210, a bi-specific construct that combines FHAB with IL-12 and human Interleukin-15 for the treatment of solid tumor is under pre-clinical trial. In addition, it develops SON-2014, a bi-specific combination of granulocyte-macrophage colony stimulating factor and Interleukin-18 for the treatment of cancer; and SON-3015, a bi-specific combination of anti-IL6 and anti-tumor growth factor beta for tumor and bone metastases. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey. Address: 100 Overlook Center, Princeton, NJ, United States, 08540

Sonnet BioTherapeutics Holdings, Inc News and around…

Latest news about Sonnet BioTherapeutics Holdings, Inc (SONN) common stock and company :

Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update
10 May, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / May 10, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three and six months ended March 31, 2022 and provided a business update.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
13 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors
13 Apr, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that dosing has been initiated in a Phase 1 clinical trial of SON-1010 (IL12-FHAB) in adult patients with advanced solid tumors.

Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting
08 Apr, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / April 8, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from preclinical studies of the company's proprietary Fully-Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410, will be presented in a poster session at the American Association for Cancer Research (AACR) Annual Meeting 2022, April 8-13, in New Orleans, Louisiana.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
08 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Get ready for another busy day of trading with our breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

16 Stocks Moving in Friday's Pre-Market Session
08 Apr, 2022 FinancialContent

Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose ...

58 Biggest Movers From Friday
21 Mar, 2022 FinancialContent

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to ...

12 Health Care Stocks Moving In Friday's Intraday Session
18 Mar, 2022 FinancialContent

Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 27.8% to $1.77 during Friday's regular session. The ...

45 Stocks Moving In Friday's Mid-Day Session
18 Mar, 2022 FinancialContent

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
18 Mar, 2022 FinancialContent

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock increased by 15.5% to $3.5 during Friday's pre-market session. The ...

25 Stocks Moving in Friday's Pre-Market Session
18 Mar, 2022 FinancialContent

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) ...

22 Stocks Moving in Thursday's Pre-Market Session
17 Mar, 2022 FinancialContent

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 ...

80 Biggest Movers From Yesterday
17 Mar, 2022 FinancialContent

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares gained 86.7% to close at $0.5150 on Wednesday after the ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
16 Mar, 2022 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of ...

Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate
16 Mar, 2022 FinancialContent

TheFDA has signed offSonnet BioTherapeutics Holdings Inc's(NASDAQ: SONN) Investigational New Drug (IND) ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
16 Mar, 2022 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The ...

Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
16 Mar, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / March 16, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for SON-1010, a proprietary version of Interleukin 12 (IL-12) configured using Sonnet's Fully Human Albumin Binding (FHAB™) technology. This will allow Sonnet to initiate its First-in-Human Phase 1 trial in adult oncology patients in the second quarter of 2022.

68 Biggest Movers From Yesterday
03 Mar, 2022 FinancialContent

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial ...

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
09 Feb, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that data from preclinical studies of the company's proprietary Fully Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410, will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, to be held April 8-13, in New Orleans, Louisiana.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
08 Feb, 2022 FinancialContent

Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The ...

Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
08 Feb, 2022 FinancialContent

PRINCETON, NJ / ACCESSWIRE / February 8, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months ended December 31, 2021 and provided a business update.

12 Health Care Stocks Moving In Monday's Pre-Market Session
07 Feb, 2022 FinancialContent

Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
02 Feb, 2022 FinancialContent

Gainers Syros Pharmaceuticals (NASDAQ:SYRS) stock increased by 12.9% to $2.18 during Wednesday's after-market session. Today's ...

12 Health Care Stocks Moving In Monday's After-Market Session
03 Jan, 2022 FinancialContent

Gainers Indaptus Therapeutics (NASDAQ:INDP) stock rose 6.6% to $6.58 during Monday's after-market session. Today's trading volume for ...

12 Health Care Stocks Moving In Thursday's After-Market Session
30 Dec, 2021 FinancialContent

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) shares rose 14.7% to $1.95 during Thursday's after-market session. At the close, Kiora ...

15 Stocks Moving In Monday's Pre-Market Session
27 Dec, 2021 FinancialContent

15 stocks that should be interesting to investors.

We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate
20 Dec, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

25 Stocks Moving in Monday's Pre-Market Session
20 Dec, 2021 FinancialContent

Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to ...

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
17 Dec, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication ...

Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update
17 Dec, 2021 FinancialContent

Sonnet BioTherapeutics Holdings, Inc (SONN) is a NASDAQ Common Stock listed in , ,

970x250